You are here

Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis

Last updated on April 10, 2019

FOR MORE INFORMATION
Study Location
bioskin GmbH
Hamburg, , 20095 Germany
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Psoriasis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Psoriasis vulgaris in a chronic stable phase and with a plaque area of mild to
moderate severity sufficient for six treatment fields located in up to three plaque
areas

- Target lesion(s) should be on the trunk or extremities (excluding palms/soles).

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- History of skin sensitivity to topical prescription or non prescription products such
as creams, lotions and cosmetics

- Psoriasis guttata, psoriasis punctata, psoriasis erythrodermatica, and pustular
psoriasis

- Treatment with any biologics within 3 months prior to Day 1 of the study and during
the study

NCT03469336
Pfizer
Completed
Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Psoriasis Vulgaris, Psoriasis Arthropathica, Pustular Psoriasis, Erythrodermic Psoriasis
NCT03885089
All Genders
0+
Years
Tokyo,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now